GLI2 Transcription Factor Mediates Cytokine Cross-talk in the Tumor Microenvironment

被引:34
作者
Elsawa, Sherine F. [1 ]
Almada, Luciana L. [1 ]
Ziesmer, Steven C. [2 ]
Novak, Anne J. [2 ]
Witzig, Thomas E. [2 ]
Ansell, Stephen M. [2 ]
Fernandez-Zapico, Martin E. [1 ]
机构
[1] Mayo Clin, Schulze Ctr Novel Therapeut, Div Oncol Res, Rochester, MN 55905 USA
[2] Mayo Clin, Div Hematol, Rochester, MN 55905 USA
基金
美国国家卫生研究院;
关键词
HEDGEHOG SIGNALING PATHWAY; MESENCHYMAL STROMAL CELLS; SCID-HU MICE; MYELOMA CELLS; MULTIPLE-MYELOMA; IN-VIVO; WALDENSTROMS MACROGLOBULINEMIA; CANCER CELLS; IMMUNOGLOBULIN SECRETION; THERAPEUTIC TARGET;
D O I
10.1074/jbc.M111.234146
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tumor cells interact with their surrounding microenvironment to survive and persist within the host. Cytokines play a key role in regulating this crosstalk between malignant cells and surrounding cells in the microenvironment. Although this phenomenon is clearly established, the molecular mechanisms mediating this cellular event remain elusive. Here, using as a model bone marrow stromal cells, we describe a novel signaling mechanism initiated by CCL5 in these cells leading to up-regulation of immunoglobulin secretion by malignant B cells. CCL5 increases IL-6 expression and secretion in bone marrow stromal cells. IL-6 in turn induces Ig secretion by malignant B cells. Analysis of the mechanism reveals that CCL5 signaling induces GLI2 through a PI3K-AKT-I kappa B alpha-p65 pathway and requires GLI2 transcriptional activity to modulate IL-6 expression and Ig secretion in vitro and in vivo. Together, these results identify a novel signaling pathway mediating the stromal-cancer cell interactions, leading to increased Ig production by malignant cells.
引用
收藏
页码:21524 / 21534
页数:11
相关论文
共 61 条
[1]  
Akira S, 1992, Semin Cancer Biol, V3, P17
[2]   The emergent design of the neural tube:: prepattern, SHH morphogan and GLI code [J].
Altaba, AR ;
Nguyên, V ;
Palma, V .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2003, 13 (05) :513-521
[3]   Interleukin 6 induces monocyte chemoattractant protein-1 expression in myeloma cells [J].
Arendt, BK ;
Velazquez-Dones, A ;
Tschumper, RC ;
Howell, KG ;
Ansell, SM ;
Witzig, TE ;
Jelinek, DF .
LEUKEMIA, 2002, 16 (10) :2142-2147
[4]  
Badache A, 2001, CANCER RES, V61, P383
[5]   Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8+ T-lymphocyte infiltration and affect tumour progression [J].
Berghuis, Dagmar ;
Santos, Susy J. ;
Baelde, Hans J. ;
Taminiau, Antonie H. M. ;
Egeler, R. Maarten ;
Schilham, Marco W. ;
Hogendoorn, Pancras C. W. ;
Lankester, Arjan C. .
JOURNAL OF PATHOLOGY, 2011, 223 (03) :347-357
[6]   WSU-WM and BCWM.1 should not be assumed to represent Waldenstrom macroglobulinemia cell lines [J].
Bergsagel, F. Leif ;
Kuehl, W. Michael .
BLOOD, 2008, 112 (03) :917-917
[7]   Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells:: Predominant role of IL-21 produced by CXCR5+ T follicular helper cells [J].
Bryant, Vanessa L. ;
Ma, Cindy S. ;
Avery, Danielle T. ;
Li, Ying ;
Good, Kim L. ;
Corcoran, Lynn M. ;
Malefyt, Rene de Waal ;
Tangye, Stuart G. .
JOURNAL OF IMMUNOLOGY, 2007, 179 (12) :8180-8190
[8]  
Burger JA, 2000, BLOOD, V96, P2655
[9]   The microenvironment in mature B-cell malignancies: a target for new treatment strategies [J].
Burger, Jan A. ;
Ghia, Paolo ;
Rosenwald, Andreas ;
Caligaris-Cappio, Federico .
BLOOD, 2009, 114 (16) :3367-3375
[10]   Functional Interaction of Plasmacytoid Dendritic Cells with Multiple Myeloma Cells: A Therapeutic Target [J].
Chauhan, Dharminder ;
Singh, Ajita V. ;
Brahmandam, Mohan ;
Carrasco, Ruben ;
Bandi, Madhavi ;
Hideshima, Teru ;
Bianchi, Giada ;
Podar, Klaus ;
Tai, Yu-Tzu ;
Mitsiades, Constantine ;
Raje, Noopur ;
Jaye, David L. ;
Kumar, Shaji K. ;
Richardson, Paul ;
Munshi, Nikhil ;
Anderson, Kenneth C. .
CANCER CELL, 2009, 16 (04) :309-323